Four-month internship (Jan–Apr 2026) in the Hematology-Oncology Unit of the Cedars Cancer Center, McGill University Health Center. Coordinated Phase I–III trials in CAR-T, bispecific antibodies, and antibody-drug conjugates and led a retrospective patient-burden study in multiple myeloma.
Hypoxia and loss of GCM1 expression prevent differentiation and contact inhibition in human trophoblast stem cells.
Under low oxygen, the GCM1 transcription factor is downregulated, and its loss blocks trophoblast differentiation and contact inhibition in human trophoblast stem cells.
Cinkornpumin JK, Kwon SY, Prandstetter AM, Maxian T, Sirois J, Goldberg J, Zhang J, Saini D, Dasgupta P, Jeyarajah MJ, Renaud SJ, Paul S, Haider S, Pastor WA
Core capabilities
Undergraduate research in the Pastor and McCaffrey labs at the Rosalind and Morris Goodman Cancer Institute: GCM1 regulation of trophoblast differentiation and placental specification, and tumour-associated macrophage activation in the DCIS-to-IDC transition in breast cancer.
Cedars Cancer Center, McGill University Health Center · Montreal, QC
Four-month internship in the Hematology-Oncology Unit of the Cedars Cancer Center, McGill University Health Center.
–
Rosalind and Morris Goodman Cancer Institute · Montreal, QC
Ran the histology service: optimized workflows to cut turnaround from 8 weeks to under 2 weeks, grew external demand, and procured major instrumentation with the resulting revenue.
–
Rosalind and Morris Goodman Cancer Institute · Montreal, QC
Honours undergraduate research project investigating tumour-associated macrophage activation in the DCIS-to-IDC transition in breast cancer.
–
Rosalind and Morris Goodman Cancer Institute · Montreal, QC
Undergraduate research into transcriptional regulation in early human development — specifically GCM1's role in trophoblast differentiation and placental specification.
–